Electropharmacological Characterization of Aciclovir in the Halothane-Anesthetized Dogs: A Proposal of Evaluation Method for Cardiovascular Safety Pharmacology of Anti-virus Drugs-Reference-Cited by-同舟云学术

Electropharmacological Characterization of Aciclovir in the Halothane-Anesthetized Dogs: A Proposal of Evaluation Method for Cardiovascular Safety Pharmacology of Anti-virus Drugs

Published:2020-03-19 Issue:4 Volume:20 Page:419-426
ISSN:1530-7905
Container-title:Cardiovascular Toxicology
language:en
Short-container-title:Cardiovasc Toxicol

Author:

Kondo Yoshiki,Hagiwara-Nagasawa Mihoko,Kambayashi Ryuichi,Goto Ai,Chiba Koki,Nunoi Yoshio,Izumi-Nakaseko Hiroko,Matsumoto Akio,Sugiyama Atsushi

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology

Link

http://link.springer.com/content/pdf/10.1007/s12012-020-09568-4.pdf

Reference16 articles.

1. Kitahara, K., Nakamura, Y., Tsuneoka, Y., Adachi-Akahane, S., Tanaka, H., Yamazaki, H., et al. (2013). Cardiohemodynamic and electrophysiological effects of anti-influenza drug oseltamivir in vivo and in vitro. Cardiovascular Toxicology,13, 234–243.

2. Cao, X., Nakamura, Y., Wada, T., Izumi-Nakaseko, H., Ando, K., & Sugiyama, A. (2016). Electropharmacological effects of amantadine on cardiovascular system assessed with J − Tpeak and Tpeak − Tend analysis in the halothane-anesthetizes beagle dogs. Journal of Toxicological Sciences,41, 439–447.

3. Iwatsubo, K., Bravo, C., Uechi, M., Baljinnyam, E., Nakamura, T., Umemura, M., et al. (2012). Prevention of heart failure in mice by an antiviral agent that inhibits type 5 cardiac adenylyl cyclase. American Journal of Physiology-Heart and Circulatory Physiology,302, 2622–2628.

4. Wada, T., Nakamura, Y., Cao, X., Ohara, H., Izumi-Nakaseko, H., Ando, K., et al. (2016). Antiviral drug vidarabine possessing cardiac type 5 adenylyl cyclase inhibitory property did not affect cardiohemodynamic or electrophysiological variables in the halothane-anesthetized dogs. Journal of Toxicological Sciences,41, 115–122.

5. Frommeyer, G., Mittelstedt, A., Wolfes, J., Ellermann, C., Kochhäuser, S., Leitz, P., et al. (2017). The anti-influenza drug oseltamivir reduces atrial fibrillation in an experimental whole-heart model. Naunyn-Schmiedeberg's Archives of Pharmacology,390, 1155–1161.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analyses of the onset mechanisms of cardio-stimulatory action by aciclovir;Journal of Pharmacological Sciences;2024-04

2. Cardiovascular safety pharmacology of ivermectin assessed using the isoflurane-anesthetized beagle dogs: ICH S7B follow-up study;The Journal of Toxicological Sciences;2023

3. In Vivo Methods in Cardiovascular Safety Pharmacology;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2022